Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 433

1.

The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.

Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM.

Kidney Int. 2019 May 7. pii: S0085-2538(19)30459-4. doi: 10.1016/j.kint.2019.03.024. [Epub ahead of print]

PMID:
31262489
2.

Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.

Garimella PS, Lee AK, Ambrosius WT, Bhatt U, Cheung AK, Chonchol M, Craven T, Hawfield AT, Jotwani V, Killeen A, Punzi H, Sarnak MJ, Wall BM, Ix JH, Shlipak MG.

Eur Heart J. 2019 Jun 30. pii: ehz392. doi: 10.1093/eurheartj/ehz392. [Epub ahead of print]

PMID:
31257404
3.

Hyperfiltration: Much Ado about Nothing?

Tummalapalli SL, Shlipak MG.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):789-791. doi: 10.2215/CJN.05330419. Epub 2019 May 23. No abstract available.

PMID:
31175079
4.

Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Am J Kidney Dis. 2019 May 22. pii: S0272-6386(19)30664-X. doi: 10.1053/j.ajkd.2019.02.024. [Epub ahead of print]

PMID:
31128770
5.

The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery.

Mansour SG, Zhang WR, Moledina DG, Coca SG, Jia Y, Thiessen-Philbrook H, McArthur E, Inoue K, Koyner JL, Shlipak MG, Wilson FP, Garg AX, Ishibe S, Parikh CR; TRIBE-AKI Consortium.

Am J Kidney Dis. 2019 Jul;74(1):36-46. doi: 10.1053/j.ajkd.2019.01.028. Epub 2019 Apr 5.

PMID:
30955944
6.

Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.

Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH; for the SPRINT Research Group.

Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.

PMID:
30939472
7.

Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.

Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, Chaves PHM, Shlipak MG, Bansal N, Sarnak MJ.

Nephrol Dial Transplant. 2019 Mar 21. pii: gfz008. doi: 10.1093/ndt/gfz008. [Epub ahead of print]

PMID:
30903163
8.

Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.

Zhang WR, Scherzer R, Estrella MM, Ascher SB, Muiru A, Jotwani V, Grunfeld C, Parikh CR, Gustafson D, Kassaye S, Sharma A, Cohen M, Tien PC, Ng DK, Palella FJ Jr, Witt MD, Ho K, Shlipak MG.

AIDS. 2019 Mar 15;33(4):723-733. doi: 10.1097/QAD.0000000000002114.

PMID:
30830887
9.

Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.

Ikeme JC, Pergola PE, Scherzer R, Shlipak MG, Catanese L, McClure LA, Benavente OR, Peralta CA.

J Am Heart Assoc. 2019 Feb 5;8(3):e010091. doi: 10.1161/JAHA.118.010091.

10.

Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study.

Muiru AN, Shlipak MG, Scherzer R, Zhang WR, Ascher SB, Jotwani V, Grunfeld C, Parikh CR, Ng D, Palella FJ Jr, Ho K, Kassaye S, Sharma A, Cohen M, Wang R, Qi Q, Estrella MM.

BMC Nephrol. 2019 Jan 3;20(1):4. doi: 10.1186/s12882-018-1192-y.

11.

Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.

Deo R, Safford MM, Khodneva YA, Jannat-Khah DP, Brown TM, Judd SE, McClellan WM, Rhodes JD, Shlipak MG, Soliman EZ, Albert CM.

J Am Coll Cardiol. 2018 Nov 13;72(20):2431-2439. doi: 10.1016/j.jacc.2018.08.2173.

PMID:
30442286
12.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
13.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
14.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium.

Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.

PMID:
30348535
15.

Association of Fibroblast Growth Factor-23 (FGF-23) With Incident Frailty in HIV-Infected and HIV-Uninfected Individuals.

Wang R, Shlipak MG, Ix JH, Brown TT, Jacobson LP, Palella FJ Jr, Lake JE, Koletar SL, Semba RD, Estrella MM.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):118-125. doi: 10.1097/QAI.0000000000001868.

PMID:
30299347
16.

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Malhotra R, Craven T, Ambrosius WT, Killeen AA, Haley WE, Cheung AK, Chonchol M, Sarnak M, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.

PMID:
30291012
17.

Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants.

Nadkarni GN, Chauhan K, Rao V, Ix JH, Shlipak MG, Parikh CR, Coca SG.

Am J Kidney Dis. 2019 Jan;73(1):31-38. doi: 10.1053/j.ajkd.2018.07.016. Epub 2018 Oct 2.

PMID:
30291011
18.

Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation.

Ascher SB, Scherzer R, Estrella MM, Zhang WR, Muiru AN, Jotwani V, Grunfeld C, Parikh CR, Gustafson D, Young M, Sharma A, Cohen MH, Ng DK, Palella FJ, Witt MD, Ho K, Shlipak MG.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1321-1329. doi: 10.2215/CJN.01700218. Epub 2018 Aug 28.

PMID:
30154221
19.

The Association of Serum Carotenoids, Tocopherols, and Ascorbic Acid With Rapid Kidney Function Decline: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Hirahatake KM, Jacobs DR, Gross MD, Bibbins-Domingo KB, Shlipak MG, Mattix-Kramer H, Odegaard AO.

J Ren Nutr. 2019 Jan;29(1):65-73. doi: 10.1053/j.jrn.2018.05.008. Epub 2018 Aug 8.

PMID:
30098859
20.

Effects of Body Size and Composition on Sex Differences in Measured GFR in a US Community-Based Older Cohort (MESA-Kidney).

Abraham AG, Shafi T, Tighiouart H, Moseley KF, Post WS, Inker LA, Coresh J, Shlipak MG, Levey AS.

Am J Kidney Dis. 2018 Nov;72(5):767-770. doi: 10.1053/j.ajkd.2018.05.012. Epub 2018 Jul 21. No abstract available.

PMID:
30041875
21.

Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.

Selamet U, Katz R, Ginsberg C, Rifkin DE, Fried LF, Kritchevsky SB, Hoofnagle AN, Bibbins-Domingo K, Drew D, Harris T, Newman A, Gutiérrez OM, Sarnak MJ, Shlipak MG, Ix JH.

Am J Kidney Dis. 2018 Sep;72(3):419-428. doi: 10.1053/j.ajkd.2018.03.026. Epub 2018 Jun 6.

PMID:
29885925
22.

Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants.

Wang CH, Rubinsky AD, Minichiello T, Shlipak MG, Price EL.

J Gen Intern Med. 2018 Aug;33(8):1299-1306. doi: 10.1007/s11606-018-4461-3. Epub 2018 May 31.

PMID:
29855865
23.

Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis.

Anuwatmatee S, Allison MA, Shlipak MG, McClelland RL, Kramer H, Tang S, Hou L, Rye KA, Ong KL.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1009-1016. doi: 10.1093/ndt/gfy120.

24.

Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.

Jotwani V, Scherzer R, Glidden DV, Mehrotra M, Defechereux P, Liu A, Gandhi M, Bennett M, Coca SG, Parikh CR, Grant RM, Shlipak MG.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):169-174. doi: 10.1097/QAI.0000000000001654.

25.

Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study.

Coresh J, Inker LA, Sang Y, Chen J, Shafi T, Post WS, Shlipak MG, Ford L, Goodman K, Perichon R, Greene T, Levey AS.

Nephrol Dial Transplant. 2019 May 1;34(5):825-833. doi: 10.1093/ndt/gfy094.

26.

Low thyroid function is not associated with an accelerated deterioration in renal function.

Meuwese CL, van Diepen M, Cappola AR, Sarnak MJ, Shlipak MG, Bauer DC, Fried LP, Iacoviello M, Vaes B, Degryse J, Khaw KT, Luben RN, Åsvold BO, Bjøro T, Vatten LJ, de Craen AJM, Trompet S, Iervasi G, Molinaro S, Ceresini G, Ferrucci L, Dullaart RPF, Bakker SJL, Jukema JW, Kearney PM, Stott DJ, Peeters RP, Franco OH, Völzke H, Walsh JP, Bremner A, Sgarbi JA, Maciel RMB, Imaizumi M, Ohishi W, Dekker FW, Rodondi N, Gussekloo J, den Elzen WPJ; Thyroid Studies Collaboration.

Nephrol Dial Transplant. 2019 Apr 1;34(4):650-659. doi: 10.1093/ndt/gfy071.

27.

Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.

Drew DA, Katz R, Kritchevsky S, Ix JH, Shlipak MG, Newman AB, Hoofnagle A, Fried L, Sarnak MJ, Gutierrez OM.

Am J Nephrol. 2018;47(4):242-250. doi: 10.1159/000488361. Epub 2018 Apr 5.

28.

Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection.

Scherzer R, Shah SJ, Secemsky E, Butler J, Grunfeld C, Shlipak MG, Hsue PY.

Circ Heart Fail. 2018 Apr;11(4):e004312. doi: 10.1161/CIRCHEARTFAILURE.117.004312.

29.

Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.

Jotwani V, Katz R, Ix JH, Gutiérrez OM, Bennett M, Parikh CR, Cummings SR, Sarnak MJ, Shlipak MG.

Am J Kidney Dis. 2018 Aug;72(2):205-213. doi: 10.1053/j.ajkd.2017.12.013. Epub 2018 Mar 27.

PMID:
29602632
30.

Racial/ethnic heterogeneity in associations of blood pressure and incident cardiovascular disease by functional status in a prospective cohort: the Multi-Ethnic Study of Atherosclerosis.

Kaiser P, Peralta CA, Kronmal R, Shlipak MG, Psaty BM, Odden MC.

BMJ Open. 2018 Feb 23;8(2):e017746. doi: 10.1136/bmjopen-2017-017746.

31.

Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study.

Meisner A, Kerr KF, Thiessen-Philbrook H, Wilson FP, Garg AX, Shlipak MG, Kavsak P, Whitlock RP, Coca SG, Parikh CR.

Biomark Res. 2018 Jan 12;6:3. doi: 10.1186/s40364-018-0117-z. eCollection 2018.

32.

Serum albumin concentration and risk of end-stage renal disease: the REGARDS study.

Walther CP, Gutiérrez OM, Cushman M, Judd SE, Lang J, McClellan W, Muntner P, Sarnak MJ, Shlipak MG, Warnock DG, Katz R, Ix JH.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1770-1777. doi: 10.1093/ndt/gfx331.

PMID:
29281114
33.

Association Between APOL1 Genotypes and Risk of Cardiovascular Disease in MESA (Multi-Ethnic Study of Atherosclerosis).

Chen TK, Katz R, Estrella MM, Gutierrez OM, Kramer H, Post WS, Shlipak MG, Wassel CL, Peralta CA.

J Am Heart Assoc. 2017 Dec 21;6(12). pii: e007199. doi: 10.1161/JAHA.117.007199.

34.

Relationship of acid-base status with arterial stiffness in community-living elders: the Health ABC Study.

Chen W, Newman AB, Fried LF, Rifkin DE, Shlipak MG, Sarnak MJ, Katz R, Madero M, Raphael KL, Bushinsky DA, Ix JH.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1572-1579. doi: 10.1093/ndt/gfx292.

PMID:
29177410
35.

Group analysis identifies differentially elevated biomarkers with distinct outcomes for advanced acute kidney injury in cardiac surgery.

Lin H, Scherzer R, Philbrook HT, Coca SG, Wilson FP, Garg AX, Shlipak MG, Parikh CR.

Biomark Med. 2017 Dec;11(12):1091-1102. doi: 10.2217/bmm-2017-0060. Epub 2017 Nov 27.

36.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

Ginsberg C, Katz R, de Boer IH, Kestenbaum BR, Chonchol M, Shlipak MG, Sarnak MJ, Hoofnagle AN, Rifkin DE, Garimella PS, Ix JH.

Bone. 2018 Feb;107:124-130. doi: 10.1016/j.bone.2017.11.011. Epub 2017 Nov 16.

37.

Longitudinal Blood Pressure Changes and Kidney Function Decline in Persons Without Chronic Kidney Disease: Findings From the MESA Study.

Judson GL, Rubinsky AD, Shlipak MG, Katz R, Kramer H, Jacobs DR Jr, Odden MC, Peralta CA.

Am J Hypertens. 2018 Apr 13;31(5):600-608. doi: 10.1093/ajh/hpx177.

38.

Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.

Lang J, Katz R, Ix JH, Gutierrez OM, Peralta CA, Parikh CR, Satterfield S, Petrovic S, Devarajan P, Bennett M, Fried LF, Cummings SR, Sarnak MJ, Shlipak MG.

Nephrol Dial Transplant. 2018 Jun 1;33(6):986-992. doi: 10.1093/ndt/gfx229.

39.

Predictors of Acute Renal Injury Study (PARIS) among HIV-positive individuals: design and methods.

Corona-Villalobos CP, Shlipak MG, Tin A, Parikh C, Moore RD, Vittinghoff E, Monroy-Trujillo JM, Atta MG, Estrella MM.

BMC Nephrol. 2017 Sep 7;18(1):289. doi: 10.1186/s12882-017-0696-1.

40.

Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.

Ishida JH, Auer R, Vittinghoff E, Pletcher MJ, Reis JP, Sidney S, Johansen KL, Bibbins-Domingo K, Peralta CA, Shlipak MG.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1578-1587. doi: 10.2215/CJN.01530217. Epub 2017 Aug 24.

41.

Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul Study.

Park M, Maristany D, Huang D, Shlipak MG, Whooley M.

Data Brief. 2017 Jul 26;14:366-370. doi: 10.1016/j.dib.2017.07.048. eCollection 2017 Oct.

42.

Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac Surgery.

Parikh CR, Puthumana J, Shlipak MG, Koyner JL, Thiessen-Philbrook H, McArthur E, Kerr K, Kavsak P, Whitlock RP, Garg AX, Coca SG.

J Am Soc Nephrol. 2017 Dec;28(12):3699-3707. doi: 10.1681/ASN.2017010055. Epub 2017 Aug 14.

43.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10.

44.

CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.

Chau KH, Scherzer R, Grunfeld C, Hsue PY, Shlipak MG.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):90-97. doi: 10.1097/QAI.0000000000001470.

45.

Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.

Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F; Chronic Kidney Disease Prognosis Consortium.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):718-728. doi: 10.1016/S2213-8587(17)30183-3. Epub 2017 Jul 14.

46.

Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study.

Park M, Maristany D, Huang D, Shlipak MG, Whooley M.

Atherosclerosis. 2017 Aug;263:68-73. doi: 10.1016/j.atherosclerosis.2017.05.021. Epub 2017 May 19.

47.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.

Foster MC, Levey AS, Inker LA, Shafi T, Fan L, Gudnason V, Katz R, Mitchell GF, Okparavero A, Palsson R, Post WS, Shlipak MG.

Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.

48.

Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis.

Inker LA, Levey AS, Tighiouart H, Shafi T, Eckfeldt JH, Johnson C, Okparavero A, Post WS, Coresh J, Shlipak MG.

Nephrol Dial Transplant. 2018 Mar 1;33(3):417-425. doi: 10.1093/ndt/gfx042.

49.

In Reply to 'Urinary Excretion of α1-Microglobulin Does Not Predict Graft Loss in Stable Kidney Transplant Recipients'.

Ix JH, Jotwani V, Shlipak MG.

Am J Kidney Dis. 2017 Jul;70(1):151-152. doi: 10.1053/j.ajkd.2017.04.010. Epub 2017 May 10. No abstract available.

PMID:
28501241
50.

Post Hoc Analyses of Randomized Clinical Trial for the Effect of Clopidogrel Added to Aspirin on Kidney Function.

Ikeme JC, Pergola PE, Scherzer R, Shlipak MG, Benavente OR, Peralta CA.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1040-1047. doi: 10.2215/CJN.00100117. Epub 2017 Apr 26.

Supplemental Content

Loading ...
Support Center